Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
202 hedge funds and large institutions have $2.7B invested in Inari Medical, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 81 increasing their positions, 44 reducing their positions, and 34 closing their positions.
84% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 44
57% more call options, than puts
Call options by funds: $15.2M | Put options by funds: $9.66M
50% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 34
9% more funds holding
Funds holding: 185 → 202 (+17)
4% more capital invested
Capital invested by funds: $2.6B → $2.7B (+$95.5M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$67.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$65.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$60.9M |
| 4 |
DCP
Darsana Capital Partners
New York
|
+$42.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$34.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$26.1M |
| 3 |
CCM
CAAS Capital Management
New York
|
-$25.8M |
| 4 |
PA
Perceptive Advisors
New York
|
-$24.7M |
| 5 |
JP Morgan Chase
New York
|
-$22.1M |
NARI Hedge Fund Activity: Q2 2021 in Review
202 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q2 2021, worth a combined $2.7B — up 3.7% from $2.6B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new NARI positions and 34 closed out — a net gain of 17 holders — while 81 added to existing stakes and 44 trimmed.
The largest buyer was BlackRock, adding an estimated $67.9M. The largest seller was Millennium Management, cutting an estimated $34.7M.
- 202 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q2 2021, up from 185 in Q1 2021.
- Funds reported $2.7B of Inari Medical, Inc. Common Stock stock for Q2 2021, up 3.7% quarter-over-quarter.
- 51 funds opened new Inari Medical, Inc. Common Stock positions in Q2 2021 and 34 closed out, a net change of +17 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q2 2021 was BlackRock, an estimated $67.9M added.
- The largest Inari Medical, Inc. Common Stock seller in Q2 2021 was Millennium Management, an estimated $34.7M sold.
Based on aggregated 13F filings for Q2 2021.